Kinase dead BTK mutations confer resistance to covalent and noncovalent BTK inhibitors but are susceptible to clinical stage BTK degraders Meeting Abstract


Authors: Montoya, S.; Bourcier, J.; Thompson, M. C.; Noviski, M.; Tan, M.; Wang, E.; Mi, X.; Brathaban, N.; Risso, C. B.; Tsai, D.; Ye, J.; Jahn, J.; Pardo, G.; Cabuhat, L.; Notti, R.; Pardo, A.; Affer, M.; Yung, S.; Luliano, J.; Powers, J.; Robbins, D. W.; Nawaratne, V.; Totiger, T. M.; Pena-Velasquez, C.; Rhodes, J. M.; Zelenetz, A. D.; Roeker, L. E.; Lu, H.; Linley, A.; Mato, A. R.; Abdel-Wahab, O.; Taylor, J.
Abstract Title: Kinase dead BTK mutations confer resistance to covalent and noncovalent BTK inhibitors but are susceptible to clinical stage BTK degraders
Meeting Title: 64th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 140
Issue: Suppl. 1
Meeting Dates: 2022 Dec 10-13
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2022-11-15
Start Page: 1811
End Page: 1813
Language: English
ACCESSION: WOS:000893223201336
DOI: 10.1182/blood-2022-163268
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Zelenetz
    768 Zelenetz
  2. Anthony R Mato
    235 Mato
  3. Lindsey Elizabeth Roeker
    132 Roeker
  4. Xiaoli Mi
    16 Mi
  5. Eric Wang
    11 Wang